How Biosimilars Could Impact Clinical Trials

Posted by: DaVita Clinical Research

Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical products which… Read more

E-Consent in a Phase 1 Setting

Posted by: DaVita Clinical Research

Informed consent to participation in a clinical trial involves substantially more than obtaining signatures from subjects on a written form. It includes providing to potential participants enough information about the… Read more

Why use a Specialty Full Service CRO?

Posted by: DaVita Clinical Research

A common trend in the drug development industry is to utilize data and innovation to safely begin participant involvement earlier and earlier in clinical trials.  As innovation continues to be… Read more